{{Rsnum
|rsid=13006529
|Gene=CASP10
|Chromosome=2
|position=201217736
|Orientation=plus
|GMAF=0.3512
|Gene_s=CASP10
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;T)
| geno3=(T;T)
| CEU | 20.0 | 46.2 | 33.8
| HCB | 6.7 | 26.7 | 66.7
| JPT | 4.5 | 20.5 | 75.0
| YRI | 9.5 | 52.4 | 38.1
| ASW | 0.0 | 0.0 | 0.0
| CHB | 6.7 | 26.7 | 66.7
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=22568453
|Title=Association of CASP3 polymorphism with hematologic toxicity in advanced NSCLC patients treated with platinum-based chemotherapy
}}

{{PMID Auto
|PMID=18563783
|Title=Genetic variants and haplotypes of the caspase-8 and caspase-10 genes contribute to susceptibility to cutaneous melanoma.
|OA=1
}}

{{PMID Auto
|PMID=19604093
|Title=Genetic polymorphisms, their allele combinations and IFN-beta treatment response in Irish multiple sclerosis patients.
|OA=1
}}

{{GET Evidence
|gene=CASP10
|aa_change=Leu522Ile
|aa_change_short=L522I
|impact=not reviewed
|qualified_impact=Insufficiently evaluated not reviewed
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs13006529
|overall_frequency_n=4721
|overall_frequency_d=10758
|overall_frequency=0.438836
|n_genomes=4
|n_genomes_annotated=0
|n_haplomes=4
|n_articles=0
|n_articles_annotated=0
|gene_in_genetests=Y
|genetests_testable=Y
|genetests_reviewed=Y
|nblosum100=-2
|autoscore=3
|n_web_uneval=2
}}

{{PMID Auto
|PMID=23212337
|Title=Role of CASP-10 gene polymorphisms in cancer susceptibility: a HuGE review and  meta-analysis
}}

{{on chip | HumanOmni1Quad}}